Anti-cea scfv-beta-lactamase contructs (cab molecules) in adept

Details Anti-cea scfv-beta-lactamase contructs (cab molecules) in adept Anti-cea scfv-beta-lactamase contructs (cab molecules) in adept

C - Chemistry, Metallurgy

07

K

C07K 19/00 (2006.01) A61K 31/195 (2006.01) A61P 35/00 (2006.01) C07K 14/245 (2006.01) C07K 16/30 (2006.01) C12N 9/86 (2006.01)

Patent

CA 2562711

The present invention relates to CAB molecules, ADEPT constructs directed against CEA, and their use in therapy.

Cette invention concerne des molécules CAB, des constructions ADEPT dirigées contre l'antigène carcinoembryonique (CEA) et leur utilisation à des fins thérapeutiques.

Affiliated with

Also associated with

Rating

Anti-cea scfv-beta-lactamase contructs (cab molecules) in adept does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-cea scfv-beta-lactamase contructs (cab molecules) in adept, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-cea scfv-beta-lactamase contructs (cab molecules) in adept will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1645943